Thursday, July 9, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Cue Biopharma, Inc.”

30 pharma patents match "Cue Biopharma, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 30
Index total 30,257
Page 1 / 2

Quick answer

This filtered view shows 30 pharmaceutical patents matching "Cue Biopharma, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

30 results for “Cue Biopharma, Inc.” · 30,257 patents in full index Clear search

  1. US 12421287

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Sep 23, 2025 · Expires Sep 18, 2045

    granted
  2. US 12257311

    Multimeric T-cell modulatory polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Mar 25, 2025 · Expires Mar 20, 2045

    granted
  3. US 12180258

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Dec 31, 2024 · Expires Dec 26, 2044

    granted
  4. US 12152061

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Nov 26, 2024 · Expires Nov 21, 2044

    granted
  5. US 12145973

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Nov 19, 2024 · Expires Nov 14, 2044

    granted
  6. US 12029782

    MHC class II T-cell modulatory multimeric polypeptides for treating type 1 diabetes mellitus (T1D) and methods of use thereof

    Cue Biopharma, Inc. · Granted Jul 9, 2024 · Expires Jul 4, 2044

    granted
  7. US 12006348

    T-cell modulatory multimeric polypeptide with conjugation sites and methods of use thereof

    Cue Biopharma, Inc. · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  8. US 11993641

    Methods for modulating an immune response

    Cue Biopharma, Inc. · Granted May 28, 2024 · Expires May 23, 2044

    granted
  9. US 11987610

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted May 21, 2024 · Expires May 16, 2044

    granted
  10. US 11958893

    Methods for modulating an immune response

    Cue Biopharma, Inc. · Granted Apr 16, 2024 · Expires Apr 11, 2044

    granted
  11. US 11905320

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Feb 20, 2024 · Expires Feb 15, 2044

    granted
  12. US 11878062

    Multimeric T-cell modulatory polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Jan 23, 2024 · Expires Jan 18, 2044

    granted
  13. US 11851471

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Dec 26, 2023 · Expires Dec 21, 2043

    granted
  14. US 11851467

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Dec 26, 2023 · Expires Dec 21, 2043

    granted
  15. US 11767355

    Methods for modulating an immune response

    Cue Biopharma, Inc. · Granted Sep 26, 2023 · Expires Sep 21, 2043

    granted
  16. US 11739133

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Aug 29, 2023 · Expires Aug 24, 2043

    granted
  17. US 11708400

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted
  18. US 11702461

    T-cell modulatory multimeric polypeptides comprising reduced-affinity immunomodulatory polypeptides

    Cue Biopharma, Inc. · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted
  19. US 11692018

    TGF-β polypeptides

    Cue Biopharma, Inc. · Granted Jul 4, 2023 · Expires Jun 29, 2043

    granted
  20. US 11530248

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted
  21. US 11505591

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  22. US 11505588

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  23. US 11479595

    Methods for modulating an immune response

    Cue Biopharma, Inc. · Granted Oct 25, 2022 · Expires Oct 20, 2042

    granted
  24. US 11401314

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted